<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231211060337N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-01-08</date_registration>
      <primary_sponsor>Combined military hospital</primary_sponsor>
      <public_title>Comparison of ultrasound guided femoropopliteal block versus spinal anesthesia for ankle surgery</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of ultrasound guided femoropopliteal block versus spinal anesthesia for ankle surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>190</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74290</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The trail randomized all patients as per the inclusion criteria furnished. The patients were divided into the spinal group and the femoropopliteal block group. Once the patients were divided into the two groups, an informed written consent was taken, and patients in both groups were explained in detail about the procedure and possible complications. Standards monitoring including non-invasive blood pressure, heart rate, capnography and ECG were attached to participants in both groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Ankle surgery.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Spinal anesthesia was administered in Group S using a standard 27 G Braun spinal needle in the L3-L4 spinal space under strict aseptic measures by a consultant anesthetist and 0.5% hyperbaric bupivacaine using a volume of 2.5 ml was administered. Onset and quality of sensory and motor block was checked and re-assessed every 2 minutes using the modified Bromage scale for motor and cold spray method for check for sensory block integrity until an effective sensory level was achieved for spinal dermatomal level T12 and below and motor block effectiveness with a Bromage score of 1. Intervention 2: Control group: Patient in the femoropopliteal block group were administered the block in prone position for the popliteal block blocking the tibial and common peroneal nerves in the popliteal space using 15ml of 0.5%bupivacaine with 2mg dexamethasone. Patients were then turned supine and 5ml of 0.5%bupivacaine with 0.5mg dexamethasone was administered in the femoral sheath for the femoral block. Both the blocks were performed under strict aseptic measures by a consultant pain specialist following standard guidelines furnished by NYSORA. Onset of the block was checked and re-assessed every two minutes until sensory and motor blocks were achieved as in the spinal group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is This will be decided at the end of the study. There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Afzal shabbir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Itefaq town nai abadi kirpa road islamabad</address>
        <city>Rawalpindi</city>
        <country1>Pakistan</country1>
        <zip>46000</zip>
        <telephone>+92 313 5158969</telephone>
        <email>afzalshabbir68@gamil.com</email>
        <affiliation>Armed Forces Post Graduate Medical Institute</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Afzal shabbir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Itefaq town nai abadi kirpa road islamabad</address>
        <city>Rawalpindi</city>
        <country1>Pakistan</country1>
        <zip>46000</zip>
        <telephone>+92 313 5158969</telephone>
        <email>afzalshabbir68@gamil.com</email>
        <affiliation>Armed Forces Post Graduate Medical Institute</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Included all ASA-I and II male and female patients between ages 25-55 years presenting for surgical fixation of malleolar fracture of the ankle.</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Included patients with major cardiac or respiratory disease, patients with failed spinal or femoropopliteal block after three unsuccessful attempts.
Patients allergic to local anesthetics including bupivacaine , lignocaine and steroids including dexamethasone.
Patients with malignancy or metastatic disease, pregnant females and patients unwilling to be included in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Spinal anesthesia was administered in Group S using a standard 27 G Braun spinal needle in the L3-L4 spinal space under strict aseptic measures by a consultant anesthetist and 0.5% hyperbaric bupivacaine using a volume of 2.5 ml was administered. Onset and quality of sensory and motor block was checked and re-assessed every 2 minutes using the modified Bromage scale for motor and cold spray method for check for sensory block integrity until an effective sensory level was achieved for spinal dermatomal level T12 and below and motor block effectiveness with a Bromage score of 1.</i_keyword>
      <i_keyword>Control group: Patient in the femoropopliteal block group were administered the block in prone position for the popliteal block blocking the tibial and common peroneal nerves in the popliteal space using 15ml of 0.5%bupivacaine with 2mg dexamethasone. Patients were then turned supine and 5ml of 0.5%bupivacaine with 0.5mg dexamethasone was administered in the femoral sheath for the femoral block. Both the blocks were performed under strict aseptic measures by a consultant pain specialist following standard guidelines furnished by NYSORA. Onset of the block was checked and re-assessed every two minutes until sensory and motor blocks were achieved as in the spinal group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>We conclude that spinal anesthesia provides early sensory and motor onset but femoropopliteal block is superior when comparing block duration and total dose of analgesia needed in 24 hours post-operatively. Timepoint: 24 hours post operative. Method of measurement: By measuring the logevity of the block.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Combined military hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-01</approval_date>
        <contact_name>Ethical comiittee of combined military hospital</contact_name>
        <contact_address>Tamizudin road , lalkurti rawalpindi Rawalpindi punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
